Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Leonardi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Cutaneous Pathology|December 1, 1996
Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genomeE Baselga, B A Drolet, A D Segura, et al.
The British Journal of Dermatology|October 18, 2005
The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaquesK B Gordon, B K Bonish, T Patel, et al.
JAMA|November 11, 1992
Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infectionG T Nahass, B A Goldstein, W Y Zhu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2018
Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasisR Gniadecki, C L Leonardi, K B Gordon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2017
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3C L Leonardi, A Blauvelt, H L Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
The British Journal of Dermatology|October 13, 2006
Efalizumab-induced autoimmune pancytopeniaW L Tom, M D Miller, M Y Hurley, et al.
Archives of Dermatology|December 1, 1993
Identification of Mycobacterium tuberculosis DNA in five different types of cutaneous lesions by the polymerase chain reactionN S Penneys, C L Leonardi, S Cook, et al.
Journal of the American Academy of Dermatology|October 1, 1993
An evaluation of oral ulcers in patients with AIDS and AIDS-related complexG S Liang, G L Daikos, U Serfling, et al.
The British Journal of Dermatology|June 20, 2018
Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switchesA Blauvelt, J-P Lacour, J F Fowler, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Cutaneous Pathology|December 1, 1996
Dermatomal lichenoid chronic graft-vs-host disease following varicella-zoster infection despite absence of viral genomeE Baselga, B A Drolet, A D Segura, et al.
The British Journal of Dermatology|October 18, 2005
The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaquesK B Gordon, B K Bonish, T Patel, et al.
JAMA|November 11, 1992
Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and varicella-zoster infectionG T Nahass, B A Goldstein, W Y Zhu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 11, 2018
Long-term optimization of outcomes with flexible adalimumab dosing in patients with moderate to severe plaque psoriasisR Gniadecki, C L Leonardi, K B Gordon, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 16, 2017
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3C L Leonardi, A Blauvelt, H L Sofen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 22, 2021
Network meta-analysis of biologic treatments for psoriasis using absolute Psoriasis Area and Severity Index values ≤1, 2, 3 or 5 derived from a statistical conversion methodU Mrowietz, R B Warren, C L Leonardi, et al.
The British Journal of Dermatology|October 13, 2006
Efalizumab-induced autoimmune pancytopeniaW L Tom, M D Miller, M Y Hurley, et al.
Archives of Dermatology|December 1, 1993
Identification of Mycobacterium tuberculosis DNA in five different types of cutaneous lesions by the polymerase chain reactionN S Penneys, C L Leonardi, S Cook, et al.
Journal of the American Academy of Dermatology|October 1, 1993
An evaluation of oral ulcers in patients with AIDS and AIDS-related complexG S Liang, G L Daikos, U Serfling, et al.
The British Journal of Dermatology|June 20, 2018
Phase III randomized study of the proposed adalimumab biosimilar GP2017 in psoriasis: impact of multiple switchesA Blauvelt, J-P Lacour, J F Fowler, et al.
Pageof 3